Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!
XU Ziyi, SUN Yuhan, FAN Li, LU Guangzhao, ZHANG Yingnan, ZHANG He. Preparation and cytotoxicity of doxorubicin-containing gold nanoparticles[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(2): 73-77, 81. doi: 10.12206/j.issn.2097-2024.202308043
Citation:
LI Jianying. Effect comparison of mifepristone combined with misoprostol and misoprostol in missed abortion curettage[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(1): 65-67. doi: 10.3969/j.issn.1006-0111.2014.01.018
Effect comparison of mifepristone combined with misoprostol and misoprostol in missed abortion curettage
Huzhou Family Planning Service Station of Zhejiang Province, Huzhou 313000, China
Received Date: 2013-05-22
Rev Recd Date:
2013-10-17
Abstract
Objective To study the clinical effect of mifepristone combined with misoprostol and misoprostol in missed abortion curettage. Methods Seventy cases from April 2010 to August 2011 of medical termination of pregnancy in Huzhou family planning service station of Zhejiang Province were collected. All cases were divided randomly into research group (38 cases) and the control group (32 cases). The patients in research group were treated with mifepristone 50 mg once per 12 h, 3 times, on 3rd day, 600 μg misoprostol 2 h before abortion curettage; the patients in control group were treated with 600 μg misoprostol 2 h before abortion curettage. Results There was no significant difference between the 2 groups in complete abortion rate (P>0.05). Vaginal bleeding time in research group was significantly less than that in control group, there was significant difference between 2 groups, with χ2=4.12 and P<0.05. Blood volume in research group was significantly less than in control group, there was significant difference between the 2 groups, with χ2=5.30, and P<0.05.The incidence of side effects of research group was significantly less than that of control group, there was significant difference between 2 groups, with χ2=5.61 and P<0.05. Conclusion Mifepristone combined with misoprostol and misoprostol only for pregnancy termination had the same clinical effect. But mifepristone combined with misoprostol could effectively reduce the vaginal bleeding time and blood loss, and have fewer side effects.
Abstract: Objective To study the clinical effect of mifepristone combined with misoprostol and misoprostol in missed abortion curettage. Methods Seventy cases from April 2010 to August 2011 of medical termination of pregnancy in Huzhou family planning service station of Zhejiang Province were collected. All cases were divided randomly into research group (38 cases) and the control group (32 cases). The patients in research group were treated with mifepristone 50 mg once per 12 h, 3 times, on 3rd day, 600 μg misoprostol 2 h before abortion curettage; the patients in control group were treated with 600 μg misoprostol 2 h before abortion curettage. Results There was no significant difference between the 2 groups in complete abortion rate (P>0.05). Vaginal bleeding time in research group was significantly less than that in control group, there was significant difference between 2 groups, with χ2=4.12 and P<0.05. Blood volume in research group was significantly less than in control group, there was significant difference between the 2 groups, with χ2=5.30, and P<0.05.The incidence of side effects of research group was significantly less than that of control group, there was significant difference between 2 groups, with χ2=5.61 and P<0.05. Conclusion Mifepristone combined with misoprostol and misoprostol only for pregnancy termination had the same clinical effect. But mifepristone combined with misoprostol could effectively reduce the vaginal bleeding time and blood loss, and have fewer side effects.
XU Ziyi, SUN Yuhan, FAN Li, LU Guangzhao, ZHANG Yingnan, ZHANG He. Preparation and cytotoxicity of doxorubicin-containing gold nanoparticles[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(2): 73-77, 81. doi: 10.12206/j.issn.2097-2024.202308043
Citation:
LI Jianying. Effect comparison of mifepristone combined with misoprostol and misoprostol in missed abortion curettage[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(1): 65-67. doi: 10.3969/j.issn.1006-0111.2014.01.018
XU Ziyi, SUN Yuhan, FAN Li, LU Guangzhao, ZHANG Yingnan, ZHANG He. Preparation and cytotoxicity of doxorubicin-containing gold nanoparticles[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(2): 73-77, 81. doi: 10.12206/j.issn.2097-2024.202308043
XU Ziyi, SUN Yuhan, FAN Li, LU Guangzhao, ZHANG Yingnan, ZHANG He. Preparation and cytotoxicity of doxorubicin-containing gold nanoparticles[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(2): 73-77, 81. doi: 10.12206/j.issn.2097-2024.202308043